<?xml version="1.0" encoding="utf-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd"><url><loc>https://www.mlo-online.com/disease/news/55396863/duke-healths-real-world-study-addresses-concerns-about-lecanemab</loc><news:news><news:publication><news:name>MLO Online</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-10T15:26:31.000Z</news:publication_date><news:title>Duke Health’s real-world study addresses concerns about lecanemab</news:title></news:news></url><url><loc>https://www.mlo-online.com/management/news/55396856/meditech-announces-new-record</loc><news:news><news:publication><news:name>MLO Online</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-10T15:19:34.000Z</news:publication_date><news:title>MEDITECH announces new record</news:title></news:news></url><url><loc>https://www.mlo-online.com/disease/news/55396848/tonix-announces-fda-alignment-on-phase-2-lyme-disease-prevention-study-for-tnx-4800</loc><news:news><news:publication><news:name>MLO Online</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-10T15:11:42.000Z</news:publication_date><news:title>Tonix announces FDA alignment on Phase 2 Lyme disease prevention study for TNX-4800</news:title></news:news></url></urlset>